Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-21-014606
Filing Date
2021-03-22
Accepted
2021-03-22 16:56:32
Documents
5
Effectiveness Date
2021-03-22

Document Format Files

Seq Description Document Type Size
1 S-8 onct-s8.htm S-8 223396
2 EX-5.1 onct-ex51_9.htm EX-5.1 26909
3 EX-10.4 onct-ex104_89.htm EX-10.4 45134
4 EX-23.1 onct-ex231_7.htm EX-23.1 3169
5 GRAPHIC gfnncxkdtjd5000001.jpg GRAPHIC 2058
  Complete submission text file 0001564590-21-014606.txt   302709
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

EIN.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254581 | Film No.: 21761925
SIC: 2834 Pharmaceutical Preparations